eSpCas9(1.1)_No_FLAG_ATP1A1_G3 Citations (4)
Originally described in: Marker-free coselection for CRISPR-driven genome editing in human cells.Agudelo D, Duringer A, Bozoyan L, Huard CC, Carter S, Loehr J, Synodinou D, Drouin M, Salsman J, Dellaire G, Laganiere J, Doyon Y Nat Methods. 2017 Apr 17. doi: 10.1038/nmeth.4265. PubMed Journal
Articles Citing eSpCas9(1.1)_No_FLAG_ATP1A1_G3
| Articles |
|---|
| A unified allosteric/torpedo mechanism for transcriptional termination on human protein-coding genes. Eaton JD, Francis L, Davidson L, West S. Genes Dev. 2020 Jan 1;34(1-2):132-145. doi: 10.1101/gad.332833.119. Epub 2019 Dec 5. PubMed |
| Gene Tagging with the CRISPR-Cas9 System to Facilitate Macromolecular Complex Purification. Geny S, Pichard S, Poterszman A, Concordet JP. Methods Mol Biol. 2021;2305:153-174. doi: 10.1007/978-1-0716-1406-8_8. PubMed |
IntAct: A nondisruptive internal tagging strategy to study the organization and function of actin isoforms.
van Zwam MC, Dhar A, Bosman W, van Straaten W, Weijers S, Seta E, Joosten B, van Haren J, Palani S, van den Dries K.
PLoS Biol. 2024 Mar 11;22(3):e3002551. doi: 10.1371/journal.pbio.3002551. eCollection 2024 Mar.
PubMed
Associated Plasmids |
| P3a site-specific and cassette mutagenesis for seamless protein, RNA and plasmid engineering. Yang XJ. Genes Cancer. 2025 Oct 31;16:34-60. doi: 10.18632/genesandcancer.243. eCollection 2025. PubMed |
If you have published an article using this material, please email us at [email protected] to have your article added to this page.